➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: June 21, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020599

Email this page to a colleague

« Back to Dashboard

NDA 020599 describes RILUTEK, which is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. Additional details are available on the RILUTEK profile page.

The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the riluzole profile page.
Summary for 020599
Formulation / Manufacturing:see details
Pharmacology for NDA: 020599
Medical Subject Heading (MeSH) Categories for 020599
Suppliers and Packaging for NDA: 020599
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RILUTEK riluzole TABLET;ORAL 020599 NDA AUTHORIZED GENERIC Rising Pharmaceuticals, Inc. 64980-191 64980-191-06 60 TABLET, FILM COATED in 1 BOTTLE (64980-191-06)
RILUTEK riluzole TABLET;ORAL 020599 NDA Covis Pharma 70515-700 70515-700-60 1 BOTTLE in 1 CARTON (70515-700-60) > 60 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 12, 1995TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.